Pharmacological chaperone design for reducing risk factor of parkinson's disease from traditional chinese medicine

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Huang, Hung Jin ^a   Lee, Cheng Chun ^b   Chen, Calvin Yu Chian ^b,c,d,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

^e Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893792231     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/830490     Document Type: Article

References (52)

1. Zimmer K. P., le Coutre P., Aerts H. M., Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation). Journal of Pathology 1999 188 4 407 414 (Pubitemid 29327440)
2. Jonsson L. M. V., Murray G. J., Sorrell S. H., Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts. European Journal of Biochemistry 1987 164 1 171 179 2-s2.0-0023099774 (Pubitemid 17053681)
3. Dasgupta N., Xu Y. H., Oh S., Gaucher disease: transcriptome analyses using microarray or mrna sequencing in a gba1 mutant mouse model treated with velaglucerase alfa or imiglucerase. PLoS One 2013 8 10 e74912
4. Cassinerio E., Graziadei G., Poggiali E., Gaucher disease: a diagnostic challenge for internists. European Journal of Internal Medicine 2013 10.1016/j.ejim.2013.09.006
5. Lieberman R. L., A guided tour of the structural biology of gaucher disease: acid-beta-glucosidase and saposin C. Enzyme Research 2011 2011 11 973231 10.4061/2011/973231
6. Schonemann W., Gallienne E., Ikeda-Obatake K., Glucosylceramide mimics: highly potent GCase inhibitors and selective pharmacological chaperones for mutations associated with types 1 and 2 Gaucher disease. ChemMedChem 2013 8 11 1805 1817 10.1002/cmdc.201300327
7. Rosenbaum H., Aharon-Peretz J., Brenner B., Hypercoagulability, parkinsonism, and Gaucher disease. Seminars in Thrombosis and Hemostasis 2013 39 8 928 934
8. Neudorfer O., Giladi N., Elstein D., Abrahamov A., Turezkite T., Achai E., Reches A., Bembi B., Zimran A., Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM 1996 89 9 691 694 2-s2.0-0029773625 (Pubitemid 26319021)
9. Li Y., Sekine T., Funayama M., Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease. Neurobiology of Aging 2013 10.1016/j.neurobiolaging.2013.09.019
10. Federoff M., Jimenez-Rolando B., Nalls M. A., Singleton A. B., A large study reveals no association between APOE and Parkinson's disease. Neurobiology of Disease 2012 46 2 389 392 2-s2.0-84859490620 10.1016/j.nbd.2012.02.002
11. Wirdefeldt K., Adami H.-O., Cole P., Trichopoulos D., Mandel J., Epidemiology and etiology of Parkinson's disease: a review of the evidence. European Journal of Epidemiology 2011 26 supplement 1 S1 S58 2-s2.0-79959728747 10.1007/s10654-011-9581-6
12. Nussbaum R. L., Ellis C. E., Alzheimer's disease and Parkinson's disease. The New England Journal of Medicine 2003 348 14 1356 1364 2-s2.0-0037417254 10.1056/NEJM2003ra020003 (Pubitemid 36384104)
13. Prensa L., Cossette M., Parent A., Dopaminergic innervation of human basal ganglia. Journal of Chemical Neuroanatomy 2000 20 3-4 207 213 2-s2.0-0034469820 10.1016/S0891-0618(00)00099-5 (Pubitemid 32162880)
14. Roede J. R., Uppal K., Park Y., Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a Pilot Study. PLoS One 2013 8 10 e77629
15. Haavik J., Toska K., Tyrosine hydroxylase and Parkinson's disease. Molecular Neurobiology 1998 16 3 285 309 2-s2.0-0031808220 (Pubitemid 28268547)
16. Olanow C. W., Jankovic J., Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy. Movement Disorders 2005 20 supplement 11 S3 S10 2-s2.0-20544431978 10.1002/mds.20457 (Pubitemid 40846905)
17. Lee C. C., Tsai C. H., Wan L., Increased incidence of Parkinsonism among Chinese with β -glucosidase mutation in central Taiwan. BioMedicine 2013 3 2 92 94
18. Chou I. C., Lin W. D., Wang C. H., Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children. BioMedicine 2013 3 2 88 91
19. Wu P. L., Lane H. Y., Tang H. S., Tsai G. E., Glutamate theory in developing novel pharmacotherapies for obsessive compulsive disorder: focusing on N-methyl-D-aspartate signaling. BioMedicine 2012 2 2 75 79
20. Wang C. H., Lin W. D., Bau D. T., Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway. BioMedicine 2013 3 2 82 87
21. Su K. P., Inflammation in psychopathology of depression: clinical, biological, and therapeutic implications. BioMedicine 2012 2 2 68 74
22. Chen K.-C., Yu-Chian Chen C., Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach. Soft Matter 2011 7 8 4001 4008 2-s2.0-79953746295 10.1039/c0sm01548b
23. Tsai T.-Y., Chang K.-W., Chen C. Y.-C., IScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan. Journal of Computer-Aided Molecular Design 2011 25 6 525 531 2-s2.0-80051545693 10.1007/s10822-011-9438-9
24. Chang S.-S., Huang H.-J., Chen C. Y.-C., Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine. PLoS Computational Biology 2011 7 12 2-s2.0-84855282742 10.1371/journal.pcbi.1002315 e1002315
25. Yang S.-C., Chang S.-S., Chen H.-Y., Chen C. Y.-C., Identification of potent EGFR inhibitors from TCM Database@Taiwan. PLoS Computational Biology 2011 7 10 2-s2.0-80055077153 10.1371/journal.pcbi.1002189 e1002189
26. Chen K.-C., Chang K.-W., Chen H.-Y., Chen C. Y.-C., Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? Molecular BioSystems 2011 7 9 2711 2719 2-s2.0-80051760684 10.1039/c1mb05164d
27. Chen K.-C., Sun M.-F., Yang S.-C., Chang S.-S., Chen H.-Y., Tsai F.-J., Chen C. Y.-C., Investigation into potent inflammation inhibitors from traditional chinese medicine. Chemical Biology and Drug Design 2011 78 4 679 688 2-s2.0-80052619174 10.1111/j.1747-0285.2011.01202.x
28. Tou W. I., Chang S. S., Lee C. C., Chen C. Y., Drug design for neuropathic pain regulation from traditional Chinese medicine. Scientific Reports 2013 3, article 844
29. Hor L. I., Chen C. L., Cytotoxins of Vibrio vulnificus: functions and roles in pathogenesis. BioMedicine 2013 3 1 19 26
30. Chen C. Y.-C., TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening In Silico. PLoS ONE 2011 6 1 2-s2.0-79251561193 10.1371/journal.pone.0015939 e15939
31. Orwig S. D., Tan Y. L., Grimster N. P., Yu Z., Powers E. T., Kelly J. W., Lieberman R. L., Binding of 3,4,5,6-tetrahydroxyazepanes to the acid- β -glucosidase active site: implications for pharmacological chaperone design for Gaucher disease. Biochemistry 2011 50 49 10647 10657 2-s2.0-82955240553 10.1021/bi201619z
32. Accelerys, Discovery Studio Client v2. 5 2009 San Diego, Calif, USA Accelrys
33. Pronk S., Pall S., Schulz R., GROMACS 4. 5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 2013 29 7 845 854
34. Cheatham T. E. III, Miller J. L., Fox T., Darden T. A., Kollman P. A., Molecular dynamics simulations on solvated biomolecular systems: the particle mesh Ewald method leads to stable trajectories of DNA, RNA, and proteins. Journal of the American Chemical Society 1995 117 14 4193 4194 2-s2.0-0029170114
35. Zoete V., Cuendet M. A., Grosdidier A., Michielin O., SwissParam: a fast force field generation tool for small organic molecules. Journal of Computational Chemistry 2011 32 11 2359 2368 2-s2.0-79958841703 10.1002/jcc.21816
36. Sun W., Sneng J., Brief Handbook of Natural Active Compounds 1998 Beijing, China Medicinal Science and Technology Press of China
37. Li M. F., Hirata Y., Xu G. J., Niwa M., Wu H. M., Studies on the chemical constituents of Dendrobium loddigesii rolfe. Acta Pharmaceutica Sinica 1991 26 4 307 310 2-s2.0-0025987939
38. Laskowski R. A., Swindells M. B., LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling 2011 51 10 2778 2786 2-s2.0-80054911951 10.1021/ci200227u
39. Tou W. I., Chen C. Y., May disordered protein cause serious drug side effect? Drug Discovery Today 2013 10.1016/j.drudis.2013.10.020
40. Chen C. Y., Tou W. I., How to design a drug for the disordered proteins? Drug Discov Today 2013 18 19-20 910 915
41. Chovancova E., Pavelka A., Benes P., CAVER 3. 0: a tool for the analysis of transport pathways in dynamic protein structures. PLOS Computational Biology 2012 8 10 e1002708
42. Chen K. C., Chang S. S., Huang H. J., Three-in-one agonists for PPAR-alpha, PPAR-gamma, and PPAR-delta from traditional Chinese medicine. Journal of Biomolecular Structure and Dynamics 2012 30 6 662 683
43. Liao W.-L., Tsai F.-J., Personalized medicine: a paradigm shift in healthcare. BioMedicine 2013 3 2 66 72
44. Tsai F.-J., Biomedicine brings the future nearer. BioMedicine 2011 1 1 1
45. Tsai F.-J., Rare diseases: a mysterious puzzle. BioMedicine 2013 3 2 65
46. Chou I. C., Lin W.-D., Wang C.-H., Möbius syndrome in a male with XX/XY mosaicism. BioMedicine 2013 3 2 102 104
47. Lee C.-C., Tsai C.-H., Wan L., Increased incidence of Parkinsonism among Chinese with β -glucosidase mutation in central Taiwan. BioMedicine 2013 3 2 92 94
48. Lin D.-Y., Tsai F.-J., Tsai C.-H., Huang C.-Y., Mechanisms governing the protective effect of 17 β -estradiol and estrogen receptors against cardiomyocyte injury. BioMedicine 2011 1 1 21 28
49. Wang C.-H., Lin W.-D., Bau D.-T., Appearance of acanthosis nigricans may precede obesity: An involvement of the insulin/IGF receptor signaling pathway. BioMedicine 2013 3 2 82 87
50. Chang Y.-M., Velmurugan B. K., Kuo W.-W., Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells. BioMedicine 2013 3 4 148 152
51. Chou I. C., Lin W.-D., Wang C.-H., Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children. BioMedicine 2013 3 2 88 91
52. Lin W.-Y., Liu H.-P., Chang J.-S., Genetic variations within the PSORS1 region affect Kawasaki disease development and coronary artery aneurysm formation. BioMedicine 2013 3 2 73 81